Itraconazole hydroxy isobutyltriazolone impurity is a synthetic byproduct formed via oxidation of an isobutyl-substituted triazolone intermediate during itraconazole synthesis. It contains a 1H-1,2,4-triazol-1-one core linked to a chlorinated naphthalene ring system, with a hydroxylated isobutyl side chain branching from the triazolone nitrogen. The structure retains the parent drugโs aromatic scaffold but incorporates an additional hydroxyl group and a modified aliphatic substituent at the triazole moiety. This impurity serves as an HPLC reference standard for quantifying oxidative degradation pathways in itraconazole API manufacturing.
On Request| Std | Catalog # | Quantity | Price |
|---|---|---|---|
| USP | 1A11100 โ | 25 mg | USD 325.00 |
CS(=O)(=O)OC[C@H]1CO[C@](O1)(CN2C=NC=N2)C3=C(C=C(C=C3)Cl)Cl
InChI=1S/C14H15Cl2N3O5S/c1-25(20,21)23-6-11-5-22-14(24-11,7-19-9-17-8-18-19)12-3-2-10(15)4-13(12)16/h2-4,8-9,11H,5-7H2,1H3/t11-,14+/m1/s1
QIMASXGTWQEFGS-RISCZKNCSA-N